CVT-1: Began Phase II trial in 200 people who will be given an American Heart Association-recommended diet for six to eight weeks to stabilize their cholesterol
CV Therapeutics, Palo Alto
Product: CVT-1, a
Gathering data...
CV Therapeutics, Palo Alto
Product: CVT-1, a